The Search for a Preventive HIV Vaccine
The past, the present and the promise
White Paper
Mar 12, 2018
Despite progress in the treatment and prevention of HIV – which has caused 35 million deaths since the early 1980s – there remains a pressing need for a preventive vaccine to help end the global pandemic. In this insight brief, IQVIA experts apply the company’s extensive experience in HIV, including 61 global treatment and prevention studies at 2,284 sites, and involving 30,170 subjects, to describe progress towards vaccine development. Areas of focus include the four vaccine concepts that have been tested; ongoing trials; lessons learned; and avenues of future research.
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.